A novel [109Pd] palladium labeled porphyrin for possible use in targeted radiotherapy

Radiochimica Acta

Volumn 96, Issue 7, 2008, Pages 427-433

  Das, T ^a   Chakraborty, S ^a   Sarma, H D ^a   Banerjee, S ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

109Pd; Porphyrin; Targeted tumor therapy

Indexed keywords

EID: 46649121718     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2008.1505     Document Type: Article

References (22)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, M., Korbrlik, M., Moan, J., Peng, Q.: Photodynamic therapy. J. Nat. Cancer Inst. 90, 889 (1998).
2. Harrod-Kim, P., Vasc, J.: Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications. Interv. Radiol. 17, 1441 (2006).
3. Whitacre, C. M., Feyes, D. K., Saloh, T., Grossmann, J., Mulvihill, J. W., Mukhtar, H., Oleinick, N. L.: Photodynamic therapy with the phthalocyanine photodensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin. Cancer Res. 6, 2021 (2000).
4. Brown, S. B., Brown, E. A., Walker, I.: The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5, 497 (2004).
5. 109Pd-porphyrin complexes for selective lymphatic ablation. J. Nucl. Med. 12, 231 (1971).
6. Hambright, P., Fawwaz, R. A, Valk, P., McRae, J., Bearden, A. J.: The distribution of various water-soluble radioactive metalloporphyrins in tumor bearing mice. Bioinorg. Chem. 5, 87 (1975).
7. 57cobalt(III) porphyrins. Inorg. Nucl. Chem. Lett. 12, 217 (1976).
8. Wong, D. W.: A simple chemical method of labeling hematoporphyrin derivative with technetium-99m. J. Label. Compd. Radiopharm. 20, 351 (1982).
9. Foster, N., Woo, D. V., Kaltovich, F., Emrich, J., Ljungquist, C.: Delenation of transplanted malignant melanoma with indium-111-labeled porphyrin. J. Nucl. Med. 26, 756 (1985).
10. 111In-labeled photofrin by glioma tissue in vivo. J. Neurooncol. 22, 7 (1994).
11. 99mTc-labeled dendritic porphyrins tumor imaging and diagnosis. Biochem. Biophys. Res. Commun. 281, 32 (2001).
12. Falk, J. E.: Porphyrins and Metalloporphyrins. Elsevier, New York (1975).
13. 109Pd-hematoporphyrin for selective lymphatic abalation using N-methylhematoporphyrin. Int. J. Appl. Radiat. Isotopes 32, 877 (1981).
14. Fawwaz, R. A., Wang, T. S. T., Srivastava, S. C., Rosen, J. M., Ferrone, S., Hardy, M. A., Alderson, P. O.: Potential of palladium-109-labeled antimelanoma monoclonal antibody for tumor therapy. J. Nucl. Med. 25, 796 (1984).
15. Chen, F. M., Troutner, D. E.: A bifunctional ligand for Pd(II). Int. J. Radiat. Appl. Instrum. B 13, 369 (1986).
16. th Edn. (Shirley, V. S., ed.) John Wiley and Sons Inc, New York (1996), p. 846-847.
17. 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy. Quart. J. Nucl. Med. Mol. Img. 51, 16 (2007).
18. Nakae, Y., Fukusaki, E., Kajiyama, S., Kobyashi, A., Nakajima, S., Sakata, I.: The convenient screening method using albumin for the tumor localizing property of Ga-Porphyrin complexes. J. Photochem. Photobiol. A: Chem. 172, 55 (2005).
19. Ricchelli, F., Franchi, L., Miotto, G., Borsetto, L., Gobbo, S., Nikolov, P., Bommer, J. C., Reddi, E.: Meso-substituted tetra-cationic porphyrin photosensitize the death of human fibrosarcoma cells via lysosomal targeting. Int. J. Biochem. Cell Biol. 37, 306 (2005).
20. Awasthi, V., Meinken, G., Springer, K., Srivastava, S. C., Freimuth, P.: Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice. J. Virol. 78, 6431 (2004).
21. Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D., Avgoustakis, K.: Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int. J. Pharm. 221, 143 (2001).
22. 177Lu labeled metronidazole for possible use in targeting tumor hypoxia. Radiochim. Acta 94, 375 (2006).